EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review

Druti Hazra iD, Connie Lam iD, Kiran Chawla iD, Vitali Sintchenko, Vijay Shree Dhyani iD, Bhumika T Venkatesh

Pharmaceutics · 15.12.2023 · 15 (12) · 2782

DOI: 10.3390/pharmaceutics15122782 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 15.12.2023. Verfasst von Druti Hazra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and persistence of drug-resistant tuberculosis is a major threat to global public health. Our objective was to assess the applicability of whole-genome sequencing (WGS) to detect genomic markers of drug resistance and explore their association with treatment outcomes for multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).

Methods

Five electronic databases were searched for studies published in English from the year 2000 onward. Two reviewers independently conducted the article screening, relevant data extraction, and quality assessment. The data of the included studies were synthesized with a narrative method and are presented in a tabular format.

Results

The database search identified 949 published articles and 8 studies were included. An unfavorable treatment outcome was reported for 26.6% (488/1834) of TB cases, which ranged from 9.7 to 51.3%. Death was reported in 10.5% (194/1834) of total cases. High-level fluoroquinolone resistance (due to gyrA 94AAC and 94GGC mutations) was correlated as the cause of unfavorable treatment outcomes and reported in three studies. Other drug resistance mutations, like kanamycin high-level resistance mutations (rrs 1401G), rpoB Ile491Phe, and ethA mutations, conferring prothionamide resistance were also reported. The secondary findings from this systematic review involved laboratory aspects of WGS, including correlations with phenotypic DST, cost, and turnaround time, or the impact of WGS results on public health actions, such as determining transmission events within outbreaks.

Conclusions

WGS has a significant capacity to provide accurate and comprehensive drug resistance data for MDR/XDR-TB, which can inform personalized drug therapy to optimize treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

drug resistancedrug therapydrug treatmentmycobacterium tuberculosistuberculosiswhole-genome sequencing

Autor:innen und Institutionen

  • Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Sydney Institute for Infectious Diseases, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
  • Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia.
  • Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Public Health Evidence South Asia, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.

ORCID-Profile: Druti Hazra, Connie Lam, Kiran Chawla, Vijay Shree Dhyani

Zitieren

APA

Hazra, D., Lam, C., Chawla, K., Sintchenko, V., Dhyani, V. S., & Venkatesh, B. T. (2023). Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review. Pharmaceutics, 15(12), 2782. https://doi.org/10.3390/pharmaceutics15122782

Vancouver

Hazra D, Lam C, Chawla K, Sintchenko V, Dhyani VS, Venkatesh BT. Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review. Pharmaceutics. 2023;15(12):2782. doi:10.3390/pharmaceutics15122782

BibTeX
@article{Hazra2023,
  author = {Hazra, Druti and Lam, Connie and Chawla, Kiran and Sintchenko, Vitali and Dhyani, Vijay Shree and Venkatesh, Bhumika T},
  title = {Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {2782},
  doi = {10.3390/pharmaceutics15122782}
}
Kostenlos starten →